1. Home
  2. LCUT vs CRDL Comparison

LCUT vs CRDL Comparison

Compare LCUT & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifetime Brands Inc.

LCUT

Lifetime Brands Inc.

HOLD

Current Price

$7.33

Market Cap

131.2M

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.36

Market Cap

154.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCUT
CRDL
Founded
1945
2017
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
131.2M
154.1M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
LCUT
CRDL
Price
$7.33
$1.36
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$5.00
$8.50
AVG Volume (30 Days)
170.3K
893.5K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
2.41%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$647,933,000.00
N/A
Revenue This Year
$3.74
N/A
Revenue Next Year
$1.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.89
$0.88
52 Week High
$8.20
$1.71

Technical Indicators

Market Signals
Indicator
LCUT
CRDL
Relative Strength Index (RSI) 61.92 51.58
Support Level $3.45 $0.95
Resistance Level $8.20 $1.43
Average True Range (ATR) 0.60 0.11
MACD -0.12 -0.02
Stochastic Oscillator 48.78 16.67

Price Performance

Historical Comparison
LCUT
CRDL

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S.-based company that designs, sources, and sells branded kitchenware, tableware, and other home solution products used in the home. The company's product portfolio comprises kitchen tools, cutlery, thermometers, cutting boards, spice racks, dinnerware, stemware, flatware, bath scales, thermal beverage ware, food storage, neoprene travel products, etc. These products are marketed under owned or licensed brands like Farberware, KitchenAid, Mikasa, Misto, Taylor, Sabatier, and Pfaltzgraff, among others. The company mainly sells its products directly to retailers and distributors, and a limited selection directly to consumers through its own websites. It has two reportable operating segments: U.S., which derives maximum revenue, and International.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

Share on Social Networks: